Perimeter Medical Imaging AI announced today that CHRISTUS St. Vincent is the first hospital in New Mexico to use the company’s S-Series OCT (Optical Coherence Tomography) technology to visualize tissue margins in the operating room. CHRISTUS St. Vincent offers the only Commission on Cancer (CoC) accredited breast cancer program in northern New Mexico.
“This evidence-based OCT technology helps me enhance my practice of using multiple tools in the operating room to help ensure that my patients have the best possible outcome,” said Dr. Amani Jambhekar, a surgical breast oncologist at CHRISTUS St. Vincent who leads a multidisciplinary team providing care for breast cancer and melanoma, as well as a high-risk breast clinic.
Traditional technologies used in the operating room such as X-ray, ultrasound or MRI don’t have the resolution to see disease at the cellular level. As a result, surgeons must wait up to 10 days for pathology results to either confirm clean margins or show positive margins, which often result in patients returning for another procedure.
The S-Series OCT uses light to create cross-sectional 3D images of tissue microstructures at 10 times the resolution of ultrasound and X-ray and 100 times the power of magnetic resonance imaging (MRI). With the ability to see down to 2 mm in ducts, vessels and glands in the operating room, surgeons can get real-time clarity on margins, giving them the insight they need to help make the best surgical decisions for their patients and feel more confident in their outcomes.
“Our flagship Perimeter S-Series OCT at CHRISTUS St. Vincent advances the company’s long-standing goal of expanding patient access to our cutting-edge technologies, offering the potential for improved patient outcomes and reduced healthcare costs to all communities,” said Perimeter CEO Adrian Mendes. “In partnership with strong patient advocate surgeons, such as Dr. Jambhekar and the team at CHRISTUS St. Vincent, we’re helping to ensure that patients can benefit from our ultra-high-resolution medical imaging technology for margin visualization right in the operating room, in real time.”
About Perimeter Medical Imaging AI, Inc.
Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that was evaluated in a pivotal clinical trial, with support from a grant of up to US$7.4 million awarded by the Cancer Prevention and Research Institute of Texas. Patient enrollment completed in September 2024, with expected FDA submission in 2025. The company’s ticker symbol “PINK” is a reference to the pink ribbons used during Breast Cancer Awareness Month.
The Editorial Team at Healthcare Business Today is made up of skilled healthcare writers and experts, led by our managing editor, Daniel Casciato, who has over 25 years of experience in healthcare writing. Since 1998, we have produced compelling and informative content for numerous publications, establishing ourselves as a trusted resource for health and wellness information. We offer readers access to fresh health, medicine, science, and technology developments and the latest in patient news, emphasizing how these developments affect our lives.
